Table 1

- Summary of studies on IA of CNS in immunocompetent patients in Saudi Arabia including the current study.

Study period	n	Age: mean(range)	Male/female	Aspergillus spp.	Treatment anti-fungal	Clinical outcome	Follow up (months)
Mohan et al⁷ (1987–92)	4	42.2 (30–60)	2/2	A. flavus (4)	Surgery/Amphotericin B	3 no recurrence	12-24 months
Mohan et al⁷ (1987–92)	4	42.2 (30–60)	2/2	A. flavus (4)	Surgery/Amphotericin B	1 death	12-24 months
Ur-Rahman⁸ et al. (1983–94)	9	47.3 (26–66)	1/8	A. flavus (6)	Surgery/Amphotericin B plus flucytosine then itraconazole	1 cured	1-36 months
				A. flavus (6)		6 residual or lost f/up
				A. fumigatus (3)		6 residual or lost f/up
				A. fumigatus (3)		2 death
Baeesa et al⁹ (2000–12)	12	32 (17–50)	4/8	not defined	Surgery/Amphotericin B plus itraconazole or variconazole	8 cured	12–50 months
						2 residual or recurrence
						2 deaths
Taha et al (2012–18)	3	33 (30–36)	3/0	not defined	Surgery/Amphotericin B plus variconazole	1 cured	1-18 months
Taha et al (2012–18)	3	33 (30–36)	3/0	not defined	Surgery/Amphotericin B plus variconazole	2 deaths	1-18 months